Botulinum toxin A for treating spasticity in adults: Costly for French hospitals?
Conclusion The daily cost of BoNTA treatment for spasticity is reasonable; however, because of the level of reimbursement by the national health insurance in France, the treatment is costly for French hospitals.
Source: Annals of Physical and Rehabilitation Medicine - Category: Rehabilitation Source Type: research
More News: Brain | Databases & Libraries | France Health | Health | Health Insurance | Insurance | Multiple Sclerosis | Neurology | Rehabilitation | Stroke | Study